Skip to main content
Premium Trial:

Request an Annual Quote

Second Genome, Virginia Commonwealth University Partner on NASH Biomarker Discovery

NEW YORK — Second Genome said on Thursday that it has partnered with Virginia Commonwealth University to discover a noninvasive stool-based biomarker for nonalcoholic steatohepatitis, an advanced inflammatory form of nonalcoholic fatty liver disease.

Second Genome said it will apply its machine learning-based sg-4sight discovery platform to patient samples, clinical metadata, and liver biopsy images provided by VCU in order to identify a composite biomarker that can be used to diagnose NASH patients with advanced fibrosis.

Specifically, Second Genome will characterize the gastrointestinal microbial taxa and microbial transcriptome in NASH and NAFLD patients, identify the composite biomarker, and then clinically validate the model in patients participating in a VCU biorepository or other studies conducted by university collaborators.

"For patients living with NASH who have advanced fibrosis, the current gold standard diagnosis is a highly invasive liver biopsy which can cause major side effects," VCU's Arun Sanyal, who is working with Second Genome on the project, said in a statement. "Second Genome's machine learning capabilities and microbial expertise will be important for developing … a novel noninvasive diagnostic marker."

In early 2020, South San Francisco, California-based Second Genome began working with Gilead Sciences to identify biomarkers for clinical responses to inflammatory bowel disease treatments.

The Scan

Open Pediatric Brain Tumor Atlas Team Introduces Genomic Data Collection, Analytical Tools

A study in Cell Genomics outlines open-source methods being used to analyze and translate whole-genome, exome, and RNA sequence data from the Pediatric Brain Tumor Atlas.

Neurological Outcomes Linked to Innate Immune Features After Cardiac Arrest

Researchers reporting in Med dig into immune features found a few hours after cardiac arrest that correspond with neurological outcomes.

Mouse Study Finds Circadian Rhythm-Related Gene Expression Changes Linked to Sleep Apnea

A paper in PLOS Biology reveals tissue-specific circadian rhythm and gene expression patterns in an intermittent hypoxia-based mouse model of obstructive sleep apnea.

Polygenic Risk Score to Predict Preeclampsia, Gestational Hypertension in Pregnant Women

Researchers in Nature Medicine provide new mechanistic insights into the development of hypertensive disorders of pregnancy, which may help develop therapeutics.